22 results
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
16 Jun 23
Entry into a Material Definitive Agreement
4:08pm
subsequent to the date of this presentation . Forward - Looking Statements
3 Nasdaq: ALBT Mission: Avalon GloboCare Corp. (Nasdaq: ALBT
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
2 May 22
Regulation FD Disclosure
4:00pm
date subsequent to the date of this presentation . Forward - Looking Statements
Mission: Avalon GloboCare Corp. (Nasdaq: AVCO) is a clinical - stage
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
14 Nov 18
Reports 30% Increase in Revenues
10:05am
will aid our mission of accelerating translational research, clinical development, and commercialization of cellular technologies and therapeutics
DEFA14A
EX-99.1
ALBT
Avalon GloboCare Corp
14 Jun 21
Additional proxy soliciting materials
9:10am
equity-linked or debt instruments will be issued in connection with the transaction.
The transaction is aligned with Avalon’s mission of developing next
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
14 Jun 21
Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction
9:12am
equity-linked or debt instruments will be issued in connection with the transaction.
The transaction is aligned with Avalon’s mission of developing next
424B2
0qphxkj
26 Apr 19
Prospectus for primary offering
5:07pm
424B4
jv5mwzpc979e
14 Aug 18
Prospectus supplement with pricing info
12:18pm
S-3/A
x7cvwi
15 Jan 19
Shelf registration (amended)
3:31pm
424B5
t7wvudm xhnejm
13 Dec 19
Prospectus supplement for primary offering
5:07pm
S-3
alkqcmi1fo3hojyn7ch
3 Jan 19
Shelf registration
12:00am